GH1 and obesity due to melanocortin 4 receptor deficiency: As there are important positive health effects associated with GH therapy in PWS—including improved body composition, better exercise capacity, increased physical activity, obesity prevention, and improvement in reaching certain cognitive and developmental milestones [57]—it is important to develop clear guidelines for patient monitoring and GH use to improve safety and efficacy.